Did You Manage To Avoid Boill Healthcare Holdings’s Devastating 85% Share Price Drop?

Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize!

Some stocks are best avoided. We really hate to see fellow investors lose their hard-earned money. Spare a thought for anyone who held Boill Healthcare Holdings Limited (HKG:1246) for five whole years – as the share price tanked 85%. And we doubt long term believers are the only worried holders, since the stock price has declined 43% over the last twelve months. Unhappily, the share price slid 2.7% in the last week.

While a drop like that is definitely a body blow, money isn’t as important as health and happiness.

Check out our latest analysis for Boill Healthcare Holdings

While markets are a powerful pricing mechanism, share prices reflect investor sentiment, not just underlying business performance. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

In the last five years Boill Healthcare Holdings improved its bottom line results, having previously been loss-making. That would generally be considered a positive, so we are surprised to see the share price is down.

Revenue is actually up 6.8% over the time period. A more detailed examination of the revenue and earnings may or may not explain why the share price languishes; there could be an opportunity.

The graphic below shows how revenue and earnings have changed as management guided the business forward. If you want to see cashflow, you can click on the chart.

SEHK:1246 Income Statement, February 22nd 2019
SEHK:1246 Income Statement, February 22nd 2019

You can see how its financial situation has strengthened (or weakened) over time in this free interactive graphic.

A Different Perspective

While the broader market lost about 7.4% in the twelve months, Boill Healthcare Holdings shareholders did even worse, losing 43%. Having said that, its inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Unfortunately, last year’s performance may indicate unresolved challenges, given that it was worse than the annualised loss of 31% over the last half decade. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. Shareholders might want to examine this detailed historical graph of past earnings, revenue and cash flow.

But note: Boill Healthcare Holdings may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on HK exchanges.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.